Christopher Mason
DirectoratKrystal Biotech· In proxies 2023–2025
Christopher Mason sits on 4 public boards.
Experience
- Krystal BiotechPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +323%
- OriBiotech Ltd.Public company · 11 yr
- Director2015 – Present · 11 yrNo stock prices for these years
- London Regenerative Medicine Network Ltd.Public company · 18 yr
- Director2008 – Present · 18 yrNo stock prices for these years
- Papillon Therapeutics Inc.Public company
- Director? – PresentNo stock prices for these years
- Stem Cell Translation Ltd.Public company · 12 yr
- Director2006 – 2018 · 12 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?